Related Experiment Video
Updated: Jun 9, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes
A Carabe-Fernandez1, R G Dale, J W Hopewell
1Department of Radiation Oncology, Harvard Medical School, Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston, MA 02114, USA. acarabe@partners.org
Physics in Medicine and Biology
|September 10, 2010
Summary
The study shows that the beta parameter
Area of Science:
- Radiation Oncology
- Medical Physics
- Radiobiology
Background:
- The linear quadratic (LQ) model is standard for radiotherapy dose-response calculations.
- Accurate relative biological effectiveness (RBE) values are crucial for high-energy transfer (LET) radiotherapy.
- The beta (β) radiosensitivity parameter's behavior with varying LET is not fully understood.
Purpose of the Study:
- To investigate the impact of the β parameter on clinical RBE calculations in high-LET radiotherapy.
- To evaluate the necessity of incorporating RBE(min) ≠ 1 in the LQ model for different radiation types.
- To assess the predictive accuracy of the modified LQ model for iso-effective doses.
Main Methods:
- Modified linear quadratic (LQ) model incorporating RBE(min).
- Fitting fractionated radiation data with RBE(min) = 1 and RBE(min) ≠ 1.
- Nonlinear regression and analysis of variance (ANOVA) for hypothesis testing.
Main Results:
- The RBE(min) ≠ 1 assumption improved model fit for neutron data in 89% of cases.
- For carbon ions, RBE(min) ≠ 1 improved fit only for normal tissues at the spread-out Bragg peak.
- The β parameter significantly impacts RBE calculations, particularly with hypofractionation of high-LET radiation.
Conclusions:
- Variations in the β parameter demonstrably affect clinical RBE calculations.
- The RBE(min) ≠ 1 modification offers improved accuracy for certain high-LET radiation types and tissues.
- This highlights the importance of considering β parameter changes in advanced radiotherapy planning.

